loading
Home   |   News   |  

Heavy! The results of the first domestic cigarette clinical study were announced

Heavy! The results of the first domestic cigarette clinical study were announced

2022-11-28

New Consumer Report of Blue Cave, November 25th, November 23, the medical SCI journal "Nicotine and Tobacco Research" published the results of the first domestic cigarette clinical study in China, which confirmed the characteristics of nicotine pharmacokinetic dynamics and cigarettes of e -cigarettes Nearly, it may be used to alleviate the "quit reaction".


This study was initiated by RELX Yue (Mist Core Technology) in March 2021. It is the first domestic clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical clinical registered registration platform (WHO ICTRP) registration platform (WHO ICTRP) registration platform (WHO ICTRP). Invention project.


The more similar to Nicotine's metabolism, the more likely it is, the more likely it is to help smokers to relieve the ring reaction. In this study, Chinese smokers were targeted for the first time. Twenty -three subjects were randomly distributed to two groups. After entering the group on the first day, they were freely smoked, and then used electronic cigarettes and cigarettes to alternate two days. Experimental personnel collect samples such as the blood of the subjects in real time, and test their heart rate, blood oxygen saturation and other indicators.


The results show that when the subject uses electronic cigarettes, the peak concentration, peak time, and absorption speed of nicotine in the plasma are similar to that of cigarettes, indicating that the nicotine delivery efficiency of the electronic cigarette is close to cigarettes. At the same time, in the same environment, the total amount of nicotine delivered by electronic cigarettes may be less.


In addition, in the experiment, all the subjects did not have severe acute symptoms, and the tolerance of electronic cigarettes was good, and some of them confirmed the short -term safety of electronic cigarettes.


Zhong Guoping, the person in charge of the research, the deputy director of the Sunsku University-Mist Core Technology atomization Science Research Center, said that the study was collected for the first time to collect the complete Chinese smokers Nigerine metabolism dynamic data, suggesting that the electronic cigarette may help smokers to relieve the symptoms of Nigerine abstinence, right Subsequent research has an important guiding role.



"This clinical study shows the impact of electronic cigarettes more clearly. We will continue to explore the scientific boundary, focus on quality and peace of mind, and further strengthen scientific and technological innovation research and development." Said Wen Yilong, the co -founder of Yue Ke, R & D and supply chain leader.


Since its establishment, Yueke has invested 800 million in the research and development field. In 2020, the company established the "1+4" scientific research path: under the premise of ensuring the quality of the product, the four major modules of physical and chemical research, toxicology research, clinical research, and long -term impact assessment were established. Scientific assessment.


According to reports, the national standard of "Electronic Cigarette" requires reducing nicotine content. The "low and high instantaneous release" technology developed under the premise of compliance can increase user satisfaction while reducing the total nicotine content. This technology has been applied to Yueke's recent launch of Phantom POWER and Qingyu series of products.


At present, Yueke is conducting research on new products that meet national standards to improve their safety and optimize their experience.


Chat Online
Chat Online
Leave Your Message inputting...
Sign in with: